BIO Annual Accounts Payable
$144.63 M
+$9.58 M+7.10%
31 December 2023
Summary:
As of January 21, 2025, BIO annual accounts payable is $144.63 million, with the most recent change of +$9.58 million (+7.10%) on December 31, 2023. During the last 3 years, it has risen by +$5.17 million (+3.71%). BIO annual accounts payable is now -2.62% below its all-time high of $148.51 million, reached on December 31, 2013.BIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Quarterly Accounts Payable
$122.19 M
-$4.51 M-3.56%
30 September 2024
Summary:
As of January 21, 2025, BIO quarterly accounts payable is $122.19 million, with the most recent change of -$4.51 million (-3.56%) on September 30, 2024. Over the past year, it has increased by +$10.33 million (+9.23%). BIO quarterly accounts payable is now -56.43% below its all-time high of $280.45 million, reached on September 30, 2016.BIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | +9.2% |
| 3 y3 years | +3.7% | -10.4% |
| 5 y5 years | +18.1% | -51.1% |
BIO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.1% | -24.1% | +18.9% |
| 5 y | 5-year | at high | +35.1% | -24.1% | +18.9% |
| alltime | all time | -2.6% | +883.8% | -56.4% | +901.5% |
Bio-Rad Laboratories Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $122.19 M(-3.6%) |
| June 2024 | - | $126.69 M(+23.3%) |
| Mar 2024 | - | $102.75 M(-29.0%) |
| Dec 2023 | $144.63 M(+7.1%) | $144.63 M(+29.3%) |
| Sept 2023 | - | $111.86 M(-25.2%) |
| June 2023 | - | $149.53 M(-7.1%) |
| Mar 2023 | - | $160.98 M(+19.2%) |
| Dec 2022 | $135.04 M(-4.9%) | $135.04 M(-5.4%) |
| Sept 2022 | - | $142.75 M(-9.8%) |
| June 2022 | - | $158.26 M(-1.5%) |
| Mar 2022 | - | $160.65 M(+13.2%) |
| Dec 2021 | $141.94 M(+1.8%) | $141.94 M(+4.1%) |
| Sept 2021 | - | $136.40 M(+2.2%) |
| June 2021 | - | $133.46 M(-3.6%) |
| Mar 2021 | - | $138.49 M(-0.7%) |
| Dec 2020 | $139.45 M(+30.3%) | $139.45 M(+4.9%) |
| Sept 2020 | - | $132.99 M(+1.6%) |
| June 2020 | - | $130.91 M(+10.7%) |
| Mar 2020 | - | $118.22 M(+10.5%) |
| Dec 2019 | $107.01 M(-12.6%) | $107.01 M(-57.2%) |
| Sept 2019 | - | $249.84 M(+1.2%) |
| June 2019 | - | $246.81 M(+3.3%) |
| Mar 2019 | - | $239.02 M(+95.2%) |
| Dec 2018 | $122.45 M(-9.4%) | $122.45 M(-52.4%) |
| Sept 2018 | - | $257.03 M(-1.8%) |
| June 2018 | - | $261.72 M(+0.9%) |
| Mar 2018 | - | $259.37 M(+91.9%) |
| Dec 2017 | $135.18 M(+1.6%) | $135.18 M(-50.7%) |
| Sept 2017 | - | $273.96 M(-1.3%) |
| June 2017 | - | $277.57 M(+19.9%) |
| Mar 2017 | - | $231.49 M(+73.9%) |
| Dec 2016 | $133.11 M(+3.5%) | $133.11 M(-52.5%) |
| Sept 2016 | - | $280.45 M(+9.5%) |
| June 2016 | - | $256.11 M(+6.2%) |
| Mar 2016 | - | $241.25 M(-10.1%) |
| Sept 2015 | - | $268.23 M(+11.8%) |
| June 2015 | - | $239.85 M(-4.4%) |
| Mar 2015 | - | $250.81 M(+95.0%) |
| Dec 2014 | $128.61 M(-13.4%) | $128.61 M(+1.6%) |
| Sept 2014 | - | $126.64 M(+0.9%) |
| June 2014 | - | $125.46 M(-4.1%) |
| Mar 2014 | - | $130.86 M(-11.9%) |
| Dec 2013 | $148.51 M(+13.5%) | $148.51 M(+12.6%) |
| Sept 2013 | - | $131.90 M(+2.2%) |
| June 2013 | - | $129.12 M(+8.2%) |
| Mar 2013 | - | $119.34 M(-8.8%) |
| Dec 2012 | $130.87 M(+1.3%) | $130.87 M(+15.5%) |
| Sept 2012 | - | $113.28 M(-5.2%) |
| June 2012 | - | $119.45 M(+9.0%) |
| Mar 2012 | - | $109.57 M(-15.1%) |
| Dec 2011 | $129.12 M(+13.8%) | $129.12 M(+13.8%) |
| Sept 2011 | - | $113.48 M(-5.8%) |
| June 2011 | - | $120.51 M(+8.2%) |
| Mar 2011 | - | $111.37 M(-1.8%) |
| Dec 2010 | $113.44 M(+22.0%) | $113.44 M(+14.4%) |
| Sept 2010 | - | $99.12 M(+4.2%) |
| June 2010 | - | $95.16 M(-4.0%) |
| Mar 2010 | - | $99.16 M(+6.6%) |
| Dec 2009 | $92.99 M(-21.2%) | $92.99 M(+0.7%) |
| Sept 2009 | - | $92.38 M(+1.7%) |
| June 2009 | - | $90.85 M(-5.3%) |
| Mar 2009 | - | $95.95 M(-18.7%) |
| Dec 2008 | $117.98 M(+22.3%) | $117.98 M(+17.2%) |
| Sept 2008 | - | $100.63 M(-1.7%) |
| June 2008 | - | $102.32 M(+3.4%) |
| Mar 2008 | - | $98.93 M(+2.5%) |
| Dec 2007 | $96.47 M(+15.7%) | $96.47 M(+41.7%) |
| Sept 2007 | - | $68.10 M(+1.3%) |
| June 2007 | - | $67.23 M(+8.5%) |
| Mar 2007 | - | $61.95 M(-25.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $83.41 M(+14.3%) | $83.41 M(+29.3%) |
| Sept 2006 | - | $64.51 M(-6.9%) |
| June 2006 | - | $69.30 M(+4.0%) |
| Mar 2006 | - | $66.64 M(-8.6%) |
| Dec 2005 | $72.95 M(+2.5%) | $72.95 M(+7.2%) |
| Sept 2005 | - | $68.08 M(-1.7%) |
| June 2005 | - | $69.25 M(+3.1%) |
| Mar 2005 | - | $67.14 M(-5.7%) |
| Dec 2004 | $71.19 M(+31.9%) | $71.19 M(+28.2%) |
| Sept 2004 | - | $55.52 M(-17.5%) |
| June 2004 | - | $67.34 M(+18.1%) |
| Mar 2004 | - | $57.03 M(+5.6%) |
| Dec 2003 | $53.99 M(-28.2%) | $53.99 M(-10.8%) |
| Sept 2003 | - | $60.52 M(+14.4%) |
| June 2003 | - | $52.89 M(-33.1%) |
| Mar 2003 | - | $79.00 M(+5.0%) |
| Dec 2002 | $75.23 M(+15.9%) | $75.23 M(+9.8%) |
| Sept 2002 | - | $68.50 M(-1.3%) |
| June 2002 | - | $69.41 M(+2.3%) |
| Mar 2002 | - | $67.85 M(+4.5%) |
| Dec 2001 | $64.90 M(+3.1%) | $64.90 M(-4.3%) |
| Sept 2001 | - | $67.83 M(+11.9%) |
| June 2001 | - | $60.62 M(-2.3%) |
| Mar 2001 | - | $62.05 M(-1.5%) |
| Dec 2000 | $62.97 M(-2.7%) | $62.97 M(+12.3%) |
| Sept 2000 | - | $56.08 M(-5.1%) |
| June 2000 | - | $59.12 M(-3.7%) |
| Mar 2000 | - | $61.40 M(-5.1%) |
| Dec 1999 | $64.70 M(+142.3%) | $64.70 M(+190.1%) |
| Sept 1999 | - | $22.30 M(-5.1%) |
| June 1999 | - | $23.50 M(-8.6%) |
| Mar 1999 | - | $25.70 M(-3.7%) |
| Dec 1998 | $26.70 M(-17.6%) | $26.70 M(+19.7%) |
| Sept 1998 | - | $22.30 M(-10.8%) |
| June 1998 | - | $25.00 M(-12.3%) |
| Mar 1998 | - | $28.50 M(-12.0%) |
| Dec 1997 | $32.40 M(+52.1%) | $32.40 M(+16.5%) |
| Sept 1997 | - | $27.80 M(+13.0%) |
| June 1997 | - | $24.60 M(+23.6%) |
| Mar 1997 | - | $19.90 M(-6.6%) |
| Dec 1996 | $21.30 M(+7.0%) | $21.30 M(+26.8%) |
| Sept 1996 | - | $16.80 M(-13.8%) |
| June 1996 | - | $19.50 M(+0.5%) |
| Mar 1996 | - | $19.40 M(-2.5%) |
| Dec 1995 | $19.90 M(-5.7%) | $19.90 M(+8.2%) |
| Sept 1995 | - | $18.40 M(-11.1%) |
| June 1995 | - | $20.70 M(-14.1%) |
| Mar 1995 | - | $24.10 M(+14.2%) |
| Dec 1994 | $21.10 M(+43.5%) | $21.10 M(+34.4%) |
| Sept 1994 | - | $15.70 M(-5.4%) |
| June 1994 | - | $16.60 M(+18.6%) |
| Mar 1994 | - | $14.00 M(-4.8%) |
| Dec 1993 | $14.70 M(-22.2%) | $14.70 M(+14.8%) |
| Sept 1993 | - | $12.80 M(-15.8%) |
| June 1993 | - | $15.20 M(-16.5%) |
| Mar 1993 | - | $18.20 M(-3.7%) |
| Dec 1992 | $18.90 M(+8.0%) | $18.90 M(+3.8%) |
| Sept 1992 | - | $18.20 M(-2.2%) |
| June 1992 | - | $18.60 M(-4.1%) |
| Mar 1992 | - | $19.40 M(+10.9%) |
| Dec 1991 | $17.50 M(-5.9%) | $17.50 M(+15.9%) |
| Sept 1991 | - | $15.10 M(-23.0%) |
| June 1991 | - | $19.60 M(+12.6%) |
| Mar 1991 | - | $17.40 M(-6.5%) |
| Dec 1990 | $18.60 M(+12.0%) | $18.60 M(+30.1%) |
| Sept 1990 | - | $14.30 M(-0.7%) |
| June 1990 | - | $14.40 M(-13.3%) |
| Mar 1990 | - | $16.60 M(0.0%) |
| Dec 1989 | $16.60 M | $16.60 M(+25.8%) |
| Sept 1989 | - | $13.20 M(+8.2%) |
| June 1989 | - | $12.20 M |
FAQ
- What is Bio-Rad Laboratories annual accounts payable?
- What is the all time high annual accounts payable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual accounts payable year-on-year change?
- What is Bio-Rad Laboratories quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly accounts payable year-on-year change?
What is Bio-Rad Laboratories annual accounts payable?
The current annual accounts payable of BIO is $144.63 M
What is the all time high annual accounts payable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual accounts payable is $148.51 M
What is Bio-Rad Laboratories annual accounts payable year-on-year change?
Over the past year, BIO annual accounts payable has changed by +$9.58 M (+7.10%)
What is Bio-Rad Laboratories quarterly accounts payable?
The current quarterly accounts payable of BIO is $122.19 M
What is the all time high quarterly accounts payable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly accounts payable is $280.45 M
What is Bio-Rad Laboratories quarterly accounts payable year-on-year change?
Over the past year, BIO quarterly accounts payable has changed by +$10.33 M (+9.23%)